Facetten
Zugriff
Einrichtung
Medientyp
- Text 11
Karte
Erscheinungsjahr
Autor/in
- Blauvelt, A
- Reich, K 9
- Langley, R G 5
- Gordon, K B 4
- Brock, F 3
- alle zeigen
Sprache
- Englisch 11
11 Einträge gefunden
-
-
Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis
2022 - Forschungsinformationssystem des UKE - frei zugänglich -
Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Long-term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3-year results from two randomized phase III trials (CIMPASI-1 and CIMPASI-2)
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studies
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
-
Assessment of the effects of immunogenicity on the pharmacokinetics, efficacy and safety of tildrakizumab
2020 - Forschungsinformationssystem des UKE -
-
-
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing Spondylitis: integrated pooled clinical trial and post-marketing surveillance data
2019 - Forschungsinformationssystem des UKE - frei zugänglich -